TCTMD

For patients with stable CAD, taking oral anticoagulation alone for 6 to 12 months following ACS or PCI is best for atrial fibrillation, leading to reduced cardiovascular mortality, major bleeding, and NACE, based on a meta-analysis. tctmd.com/news/oral-anti…

Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1 dlvr.it/TRb0w4

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide dlvr.it/TRZzdp

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk dlvr.it/TRZvZW

Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF dlvr.it/TRZFJf

The Agent drug-coated balloon continues to hold an advantage over uncoated balloon angioplasty alone in high-risk patients with in-stent restenosis, according to a new 3-year follow-up data from AGENT IDE. More here: tctmd.com/news/agent-ide… #CRT2026

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines dlvr.it/TRZ6vV

No Major Progress on Making CV Care More Affordable: JACC Stats dlvr.it/TRZ4qw

What can you expect from this year's #ACC2026? Listen to @Drroxmehran, Katie Berlacher, and the president of the @ACCinTouch @ChrisKramerMD give a preview of what's to come at the conference in New Orleans on this latest episode of Rox Heart Radio. tctmd.com/audio/rox-hear…

Rox Heart Radio: On the Cusp of ACC 2026 dlvr.it/TRYpDb

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years dlvr.it/TRY82l

Ultraprocessed Food Again Linked to Higher CVD Risk: MESA dlvr.it/TRY69b

During this year's #THT2026, several sessions focused on how AI is quickly transforming heart failure care, from screening and diagnosis to treatment. But the question of how to utilize the tool to better optimize patient care remains. tctmd.com/news/ai-heart-…

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBBRA dlvr.it/TRX3h2

CARPOOL Radial Access as Good as Femoral in PAD Procedures dlvr.it/TRX37W

Stress May Augment Impact of Adverse Pregnancy Outcomes on CV Health dlvr.it/TRX27q

Two trials, the DOBERMANN-D and DOBERMANN-T, show possible promising effects of inotropic therapy and a monoclonal antibody in high-risk acute MI patients, even though they fell short of lowering NT-proBNP after PCI, their primary endpoints. Read more here: tctmd.com/news/dobermann… #CRT2026

With the rise of AI, the regulatory and ethical sides of using the tool need to be addressed. TCTMD's Todd Neale sits down with @AmiBhattMD to discuss building infrastructure and guardrails for AI and what clinicians can do to participate in the effort. tctmd.com/videos/on-reco… #THT2026

SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type dlvr.it/TRWgkk

Is there enough existing evidence to perform TEER in patients with heart failure and moderate functional mitral regurgitation? Experts debated that topic at the recent #THT2026, with the general consensus being that more data is needed. tctmd.com/news/should-mo…